Roadmap: Helium ion therapy

Andrea Mairani, Stewart Mein, Eleanor Blakely, Jurgen Debus, Marco Durante, Alfredo Ferrari, Hermann Fuchs, Dietmar Georg, David R. Grosshans, Fada Guan, Thomas Haberer, Semi Harrabi, Felix Horst, Taku Inaniwa, Christian P. Karger, Radhe Mohan, Harald Paganetti, Katia Parodi, Paola Sala, Christoph SchuyThomas Tessonnier, Uwe Titt, Ulrich Weber

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

Helium ion beam therapy for the treatment of cancerwas one of several developed and studied particle treatments in the 1950s, leading to clinical trials beginning in 1975 at the Lawrence Berkeley National Laboratory. The trial shutdown was followed by decades of research and clinical silence on the topic while proton and carbon ion therapymade debuts at research facilities and academic hospitalsworldwide.The lack of progression in understanding the principle facets of helium ion beam therapy in terms of physics, biological and clinical findings persists today, mainly attributable to its highly limited availability.Despite this major setback, there is an increasing focus on evaluating and establishing clinical and research programs using heliumion beams, with both therapy and imaging initiatives to supplement the clinical palette of radiotherapy in the treatment of aggressive disease and sensitive clinical cases. Moreover, due its intermediate physical and radio-biological properties between proton and carbon ion beams, helium ions may provide a streamlined economic steppingstone towards an era of widespread use of different particle species in light and heavy ion therapy. With respect to the clinical proton beams, helium ions exhibit superior physical properties such as reduced lateral scattering and range stragglingwith higher relative biological effectiveness (RBE) and dose-weighted linear energy transfer (LETd) ranging from 4keVum?1 to 40 keVum?1. In the frame of heavy ion therapy using carbon, oxygen or neon ions,where LETd increases beyond 100 keVum?1, helium ions exhibit similar physical attributes such as a sharp lateral penumbra, however,with reduced radio-biological uncertainties and without potentially spoiling dose distributions due to excess fragmentation of heavier ion beams, particularly for higher penetration depths. This roadmap presents an overviewof the current state-of-The-Art and future directions of heliumion therapy: understanding physics and improvingmodeling, understanding biology and improving modeling, imaging techniques using helium ions and refining and establishing clinical approaches and aims from learned experiencewith protons.These topics are organized and presented into three main sections, outlining current and future tasks in establishing clinical and research programs using helium ion beams A. PhysicsB.Biological and C. Clinical Perspectives.

Original languageEnglish (US)
Article number15TR02
JournalPhysics in medicine and biology
Volume67
Issue number15
DOIs
StatePublished - Aug 7 2022

Keywords

  • Dosimetry
  • helium ion therapy
  • Imaging
  • Medical physics
  • Radiation biology

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Roadmap: Helium ion therapy'. Together they form a unique fingerprint.

Cite this